drugset / Trial / NCT06273215
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Non-randomizedParallel-groupOpen-labelBasic science
Summary
1.To explore the functional changes of P-gp, CYP3A4, OATP1B and BCRP in Diabetic patients (including the non-obese T2DM, obese T2DM, elderly T2DM, and T1DM).
Timeline
- Start
- 2023-03-05
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 100 ug | — |
| Subject | Dabigatran etexilate | Unknown | 375 ug | — |
| Subject | Midazolam | Small molecule | 10 ug | — |
| Subject | Pitavastatin | Small molecule | 10 ug | — |
| Subject | Rosuvastatin | Small molecule | 50 ug | — |